Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristian Casem
Institution:
Memorial Sloan Kettering Cancer Center
Observed institution:
Memorial Sloan Kettering Cancer Center
ORCID:
0009-0008-3018-9613
Observed ORCID:
0009-0008-3018-9613
OpenAlex ID:
A5117712396
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
2025
·
Ioannis Politikos
, Samantha Brown
, et al.
·
Blood Advances
·
4
PDF
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation
2026
·
Kristian Casem
, Stephanie Monaco-Cermak
, et al.
·
Bone Marrow Transplantation
Effect of Mycophenolate Mofetil Levels on Transplant Outcomes in Patients Treated with Post-Transplant Cyclophosphamide Based GVHD Prophylaxis
2026
·
Andrew Lin
, Samantha Brown
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
3
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type
